About Spur Therapeutics
Spur Therapeutics is a company based in Stevenage (United Kingdom) founded in 2015 was acquired by Syncona in November 2023. It operates as a B2B, and Partnerships. Spur Therapeutics offers products and services including FLT201, Gene Therapy for Parkinson’s, and Gene Therapy for AMN. Spur Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Biogen, Senti Biosciences, Neurocrine and PTC Therapeutics, among others.
- Headquarter Stevenage, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spur Therapeutics
Spur Therapeutics offers a comprehensive portfolio of products and services, including FLT201, Gene Therapy for Parkinson’s, and Gene Therapy for AMN. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gene therapy candidate for treating Gaucher Disease.
Therapy aimed at modifying Parkinson’s Disease progression.
First-in-class treatment for adrenomyeloneuropathy.
Funding Insights of Spur Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spur Therapeutics
Spur Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Syncona. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare investments are managed via private equity by Syncona.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spur Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spur Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spur Therapeutics Comparisons
Competitors of Spur Therapeutics
Spur Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Biogen, Senti Biosciences, Neurocrine and PTC Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of small molecule therapeutics for endocrine and CNS disorders
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for neurological and neuropsychiatric diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spur Therapeutics
Frequently Asked Questions about Spur Therapeutics
When was Spur Therapeutics founded?
Spur Therapeutics was founded in 2015.
Where is Spur Therapeutics located?
Spur Therapeutics is headquartered in Stevenage, United Kingdom. It is registered at Stevenage, Hertfordshire, United Kingdom.
What does Spur Therapeutics do?
Spur Therapeutics is a clinical-stage biotech firm focused on developing gene therapies that optimize components for effective treatment of chronic conditions. They target diseases such as Gaucher Disease, Parkinsons Disease, and AMN through clinical trials and innovative approaches. Based in the United Kingdom and United States, they emphasize partnerships and aim to halt disease progression with single-dose therapies. Their pipeline reflects a commitment to transforming genetic medicine for broader impact.
Who are the top competitors of Spur Therapeutics?
Spur Therapeutics's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
What products or services does Spur Therapeutics offer?
Spur Therapeutics offers FLT201, Gene Therapy for Parkinson’s, and Gene Therapy for AMN.
Who are Spur Therapeutics's investors?
Spur Therapeutics has 1 investor. Key investors include Syncona.